Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI052441-02
Application #
6768766
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Johnson, David R
Project Start
2003-07-01
Project End
2007-12-31
Budget Start
2004-01-01
Budget End
2004-12-31
Support Year
2
Fiscal Year
2004
Total Cost
$292,253
Indirect Cost

  Institution

Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045

  Publications

Thurman, Joshua M; Tchepeleva, Svetlana N; Haas, Mark et al. (2012) Complement alternative pathway activation in the autologous phase of nephrotoxic serum nephritis. Am J Physiol Renal Physiol 302:F1529-36
Tchepeleva, Svetlana N; Thurman, Joshua M; Ruff, Katherine et al. (2010) An allelic variant of Crry in the murine Sle1c lupus susceptibility interval is not impaired in its ability to regulate complement activation. J Immunol 185:2331-9
Giles, Brendan M; Tchepeleva, Svetlana N; Kachinski, Julie J et al. (2007) Augmentation of NZB autoimmune phenotypes by the Sle1c murine lupus susceptibility interval. J Immunol 178:4667-75